June 29, 2016
John A. Hovanesian, MD, FACS
The U.S. Food and Drug Administration has approved the Raindrop near vision inlay for implantation in the cornea to improve near vision in some patients with presbyopia, the agency announced in a press release.
The Raindrop inlay (ReVision Optics) is the second FDA-approved implantable corneal device for correction of near vision in patients who have not had cataract surgery, and the first device to change the shape of the cornea to correct vision, the release said.
In the JournalsPerspective
June 21, 2016
Topography-guided transepithelial surface ablation improved vision and reduced moderate to high astigmatism, according to a study. The retrospective study included 206…
June 14, 2016
Presbyopic patients who were treated with EV06 ophthalmic solution showed an improvement in visual outcomes in a phase 1/2 study, Encore Vision announced in a press…
In the Journals
June 13, 2016
By 2050, non-Hispanic white individuals are still expected to represent the largest prevalence of vision impairment cases in the United States. Increasing vision…